Literature DB >> 19884331

Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.

Mary N Burtnick1, David DeShazer, Vinod Nair, Frank C Gherardini, Paul J Brett.   

Abstract

Burkholderia mallei is a facultative intracellular pathogen that causes severe disease in animals and humans. Recent studies have shown that the cluster 1 type VI secretion system (T6SS-1) expressed by this organism is essential for survival in a hamster model of glanders. To better understand the role of T6SS-1 in the pathogenesis of disease, studies were initiated to examine the interactions of B. mallei tssE mutants with RAW 264.7 murine macrophages. Results obtained by utilizing modified gentamicin protection assays indicated that although the tssE mutants were able to survive within RAW 264.7 cells, significant growth defects were observed in comparison to controls. In addition, analysis of infected monolayers by differential interference contrast and fluorescence microscopy demonstrated that the tssE mutants lacked the ability to induce multinucleated giant cell formation. Via the use of fluorescence microscopy, tssE mutants were shown to undergo escape from lysosome-associated membrane protein 1-positive vacuoles. Curiously, however, following entry into the cytosol, the mutants exhibited actin polymerization defects resulting in inefficient intra- and intercellular spread characteristics. Importantly, all mutant phenotypes observed in this study could be restored by complementation. Based upon these findings, it appears that T6SS-1 plays a critical role in growth and actin-based motility following uptake of B. mallei by RAW 264.7 cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19884331      PMCID: PMC2798217          DOI: 10.1128/IAI.00985-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

1.  Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading.

Authors:  W Kespichayawattana; S Rattanachetkul; T Wanun; P Utaisincharoen; S Sirisinha
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Multinucleated giant cell formation and apoptosis in infected host cells is mediated by Burkholderia pseudomallei type III secretion protein BipB.

Authors:  Supaporn Suparak; Wannapa Kespichayawattana; Ashraful Haque; Anna Easton; Suwat Damnin; Ganjana Lertmemongkolchai; Gregory J Bancroft; Sunee Korbsrisate
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

3.  Type VI secretion is a major virulence determinant in Burkholderia mallei.

Authors:  Mark A Schell; Ricky L Ulrich; Wilson J Ribot; Ernst E Brueggemann; Harry B Hines; Dan Chen; Lyla Lipscomb; H Stanley Kim; Jan Mrázek; William C Nierman; David Deshazer
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

4.  Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; Paul J Brett; Vinod Nair; Jonathan M Warawa; Donald E Woods; Frank C Gherardini
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

5.  Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture.

Authors:  V S Harley; D A Dance; B S Drasar; G Tovey
Journal:  Microbios       Date:  1998

6.  Molecular characterization of a functional type VI secretion system from a clinical isolate of Aeromonas hydrophila.

Authors:  Giovanni Suarez; Johanna C Sierra; Jian Sha; Shaofei Wang; Tatiana E Erova; Amin A Fadl; Sheri M Foltz; Amy J Horneman; Ashok K Chopra
Journal:  Microb Pathog       Date:  2007-10-24       Impact factor: 3.738

7.  Burkholderia mallei cellular interactions in a respiratory cell model.

Authors:  Gregory C Whitlock; Gustavo A Valbuena; Vsevolod L Popov; Barbara M Judy; D Mark Estes; Alfredo G Torres
Journal:  J Med Microbiol       Date:  2009-05       Impact factor: 2.472

8.  Experimental aerogenic Burkholderia mallei (glanders) infection in the BALB/c mouse.

Authors:  M Stephen Lever; Michelle Nelson; Philip I Ireland; Anthony J Stagg; Richard J Beedham; Graham A Hall; Georgina Knight; Richard W Titball
Journal:  J Med Microbiol       Date:  2003-12       Impact factor: 2.472

9.  A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants.

Authors:  T T Hoang; R R Karkhoff-Schweizer; A J Kutchma; H P Schweizer
Journal:  Gene       Date:  1998-05-28       Impact factor: 3.688

10.  iNOS activity is critical for the clearance of Burkholderia mallei from infected RAW 264.7 murine macrophages.

Authors:  Paul J Brett; Mary N Burtnick; Hua Su; Vinod Nair; Frank C Gherardini
Journal:  Cell Microbiol       Date:  2007-10-28       Impact factor: 3.715

View more
  49 in total

1.  Burkholderia mallei CLH001 Attenuated Vaccine Strain Is Immunogenic and Protects against Acute Respiratory Glanders.

Authors:  Christopher L Hatcher; Tiffany M Mott; Laura A Muruato; Elena Sbrana; Alfredo G Torres
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

2.  VgrG-5 is a Burkholderia type VI secretion system-exported protein required for multinucleated giant cell formation and virulence.

Authors:  Sandra Schwarz; Pragya Singh; Johanna D Robertson; Michele LeRoux; Shawn J Skerrett; David R Goodlett; T Eoin West; Joseph D Mougous
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

3.  Regulation of type VI secretion system during Burkholderia pseudomallei infection.

Authors:  Yahua Chen; Jocelyn Wong; Guang Wen Sun; Yichun Liu; Gek-Yen Gladys Tan; Yunn-Hwen Gan
Journal:  Infect Immun       Date:  2011-06-13       Impact factor: 3.441

4.  In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation.

Authors:  Amy T Ma; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-11       Impact factor: 11.205

5.  Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay.

Authors:  Mohamad A Hamad; Alexander M Skeldon; Miguel A Valvano
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

Review 6.  Combating the great mimicker: latest progress in the development of Burkholderia pseudomallei vaccines.

Authors:  Nittaya Khakhum; Itziar Chapartegui-González; Alfredo G Torres
Journal:  Expert Rev Vaccines       Date:  2020-07-15       Impact factor: 5.217

Review 7.  Melioidosis: molecular aspects of pathogenesis.

Authors:  Joshua K Stone; David DeShazer; Paul J Brett; Mary N Burtnick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10-14       Impact factor: 5.091

8.  The twin arginine translocation system is essential for aerobic growth and full virulence of Burkholderia thailandensis.

Authors:  Sariqa Wagley; Claudia Hemsley; Rachael Thomas; Madeleine G Moule; Muthita Vanaporn; Clio Andreae; Matthew Robinson; Stan Goldman; Brendan W Wren; Clive S Butler; Richard W Titball
Journal:  J Bacteriol       Date:  2013-11-08       Impact factor: 3.490

9.  Promoter swapping unveils the role of the Citrobacter rodentium CTS1 type VI secretion system in interbacterial competition.

Authors:  Erwan Gueguen; Eric Cascales
Journal:  Appl Environ Microbiol       Date:  2012-10-12       Impact factor: 4.792

10.  Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions.

Authors:  Sandra Schwarz; T Eoin West; Frédéric Boyer; Wen-Chi Chiang; Mike A Carl; Rachel D Hood; Laurence Rohmer; Tim Tolker-Nielsen; Shawn J Skerrett; Joseph D Mougous
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.